Genomic Testing


FoundationOne® Liquid is a next-generation liquid biopsy test for solid tumours utilizing circulating tumour DNA (ctDNA). This test may be considered to complement solid tissue results or when tissue is not ideal.
    Analyses blood samples from patients with solid tumours including lung, breast, colon, etc.
    Two tubes of peripheral whole blood (10mL per tube)
    2 weeks

What is FoundationOne Liquid?

This liquid biopsy test provides targeted gene and microsatellite instability (MSI) results1 that can help inform next-steps for advanced-stage cancer patients using a minimally invasive sample type. By analyzing ctDNA with our comprehensive genomic profiling approach and providing curated reports, FoundationOne Liquid empowers providers to make more informed clinical decisions even when tissue is not ideal.


FoundationOne Liquid

  1. A single liquid biopsy test that detects the 4 known classes of genomic alterations
  2. Can provide a comprehensive genomic profile including resistance mutations or fusions in lung cancer1
  3. Includes MSI statusa and homologous recombination deficiency (HRD) genes to help guide next-step options for patients
  4. Requires only two 10 mL tubes of blood

a. MSI status will be reported for samples determined to have high microsatellite instability.

Order FoundationOne Liquid

We provide physicians with several options for ordering FoundationOne Liquid for patients including fax and phone. Healthcare providers must first complete a test requisition form to start the process and can expect results within 2 weeks from the time a tissue specimen is received at the lab location.

Order Genomic Test with Your Doctor


FoundationOne Liquid is ordered by your healthcare provider. Our patient info kit has all the information you and your doctor need to discuss FoundationOne Liquid testing.

Download Patient Brochure

Health Care Practitioners

FoundationOne Liquid can be ordered by fax or by phone. Please review and complete the provider resources before ordering.

Order Now